ABSTRACT
Registered Substances ........................................................................29 3.3 Title III-Data Sharing and Avoidance of Unnecessary Testing:
Chapter 3-Rules for Phase-In-Substances ...................................................30 3.3.1 REACH Article 28-Duty to Preregister for Phase-In Substances ...30 3.3.2 REACH Article 29-Substance Information Exchange Forums .......30 3.3.3 REACH Article 30-Sharing of Data Involving Tests ...................... 31
3.4 Title VI-Evaluation: Chapter 1-Dossier Evaluation .................................. 32 3.4.1 REACH Article 40-Examination of Testing Proposals ................... 32 3.4.2 REACH Article 49-Further Information on On-Site Isolated
Intermediates ...................................................................................... 32 3.5 Title VI-Evaluation: Chapter 4-Common Provisions ............................... 33
3.5.1 REACH Article 53-Cost Sharing for Tests without an Agreement between Registrants and DUs .......................................... 33
3.6 Title VII-Authorization: Chapter 1-Authorization Requirement .............. 33 3.6.1 REACH Article 55-Aim of Authorization and Considerations
for Substitution .................................................................................... 33 3.6.2 REACH Article 56-General Provisions ...........................................34
